Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Anagrelide and the CALR mutation allele burden in essential thrombocythemia.

Experimental oncology - 1 Jun 2018

Atkinson E, Bakri M, Hayat A, Langabeer S E

Abstract excerpt

No abstract is available from the source.

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Aged
Share to Alleles
Share to Calreticulin
Share to Mutation

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Platelet Aggregation Inhibitors

Share to Platelet Count

Share to Quinazolines

Share to Thrombocythemia, Essential

Source

Identifiers

PMID: 29949532

Genes

CALR

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 4 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Anagrelide and the CALR mutation allele burden in essential thrombocythemia.PMID 29949532Read ↗

The mutant CALR allele burden in essential thrombocythemia at transformation to acute myeloid leukemia.Semantic proximity Read ↗

Anagrelide and Mutational Status in Essential Thrombocythemia.Semantic proximity Read ↗

Interferon alfa therapy in CALR-mutated essential thrombocythemia.Semantic proximity Read ↗

Long-term follow-up of essential thrombocythemia patients treated with anagrelide: subgroup analysis according to JAK2/CALR/MPL mutational status.Semantic proximity Read ↗

Essential Thrombocythemia Associated With Germline JAK2 G571S Variant and Somatic CALR Type 1 Mutation.Semantic proximity Read ↗

CALR mutation burden in essential thrombocythemia and disease outcome.Semantic proximity Read ↗

Comparative thrombotic risk associated with CALR1 , CALR2 , and JAK2 V617F mutations in essential thrombocythemiaSemantic proximity Read ↗

Frequency and allele burden of CALR mutations in Chinese with essential thrombocythemia and primary myelofibrosis without JAK2(V617F) or MPL mutations.Semantic proximity Read ↗

Hematological relevance of JAK2 V617F and calreticulin mutations in Tunisian patients with essential thrombocythemia.Semantic proximity Read ↗

Published guidelines versus real-life practice in the diagnosis and treatment of essential thrombocythemia.Semantic proximity Read ↗

Clinical implications of the JAK2 V617F mutation in essential thrombocythemiaSemantic proximity Read ↗

JAK2V617F and CALR double mutations are more frequently encountered in patients with low JAK2V617F allelic burdens.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.